Stem cells and diabetic complications — research overview
Diabetic nephropathy is a leading cause of end-stage renal disease. Research has examined whether mesenchymal stromal cells (MSCs) might reduce inflammatory responses and limit kidney damage in experimental and preclinical studies. These findings are investigational and are not an established or authorised treatment. This page is for information and education only.
